BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24984960)

  • 1. Axl mediates tumor invasion and chemosensitivity through PI3K/Akt signaling pathway and is transcriptionally regulated by slug in breast carcinoma.
    Li Y; Jia L; Ren D; Liu C; Gong Y; Wang N; Zhang X; Zhao Y
    IUBMB Life; 2014 Jul; 66(7):507-18. PubMed ID: 24984960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma.
    Li Y; Jia L; Liu C; Gong Y; Ren D; Wang N; Zhang X; Zhao Y
    Tumour Biol; 2015 Feb; 36(2):1115-27. PubMed ID: 25327287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway.
    Xu J; Jia L; Ma H; Li Y; Ma Z; Zhao Y
    Tumour Biol; 2014 Apr; 35(4):3809-17. PubMed ID: 24347489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas6/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt/GSK-3β/β-catenin Signaling.
    Wang C; Jin H; Wang N; Fan S; Wang Y; Zhang Y; Wei L; Tao X; Gu D; Zhao F; Fang J; Yao M; Qin W
    Theranostics; 2016; 6(8):1205-19. PubMed ID: 27279912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
    J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway.
    Ma Y; Zhou G; Li M; Hu D; Zhang L; Liu P; Lin K
    Neurochem Int; 2018 Sep; 118():233-241. PubMed ID: 29572052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.
    Holland SJ; Pan A; Franci C; Hu Y; Chang B; Li W; Duan M; Torneros A; Yu J; Heckrodt TJ; Zhang J; Ding P; Apatira A; Chua J; Brandt R; Pine P; Goff D; Singh R; Payan DG; Hitoshi Y
    Cancer Res; 2010 Feb; 70(4):1544-54. PubMed ID: 20145120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells.
    Asiedu MK; Beauchamp-Perez FD; Ingle JN; Behrens MD; Radisky DC; Knutson KL
    Oncogene; 2014 Mar; 33(10):1316-24. PubMed ID: 23474758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.
    Dunne PD; McArt DG; Blayney JK; Kalimutho M; Greer S; Wang T; Srivastava S; Ong CW; Arthur K; Loughrey M; Redmond K; Longley DB; Salto-Tellez M; Johnston PG; Van Schaeybroeck S
    Clin Cancer Res; 2014 Jan; 20(1):164-75. PubMed ID: 24170546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKT drives sustained motility following MEK inhibition via promoting SNAIL and AXL in MDA-MB-231 LM2.
    Kwon J; Helfman DM; Kim MY
    Biochem Biophys Res Commun; 2020 Jul; 528(1):92-98. PubMed ID: 32456793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
    Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
    Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.
    Abdel-Rahman WM; Al-Khayyal NA; Nair VA; Aravind SR; Saber-Ayad M
    World J Gastroenterol; 2017 May; 23(19):3440-3448. PubMed ID: 28596680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer.
    Vuoriluoto K; Haugen H; Kiviluoto S; Mpindi JP; Nevo J; Gjerdrum C; Tiron C; Lorens JB; Ivaska J
    Oncogene; 2011 Mar; 30(12):1436-48. PubMed ID: 21057535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.
    Yang Q; Ji G; Li J
    Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
    Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
    Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
    Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
    Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ST6GalNAcII mediates the invasive properties of breast carcinoma through PI3K/Akt/NF-κB signaling pathway.
    Ren D; Jia L; Li Y; Gong Y; Liu C; Zhang X; Wang N; Zhao Y
    IUBMB Life; 2014 Apr; 66(4):300-8. PubMed ID: 24756995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma.
    Wang H; Xu L; Zhu X; Wang P; Chi H; Meng Z
    Oncol Rep; 2014 Oct; 32(4):1465-72. PubMed ID: 25070581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.